Literature DB >> 29661717

Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases.

Canan Kelten Talu1, Cem Leblebici2, Tulin Kilicaslan Ozturk3, Ezgi Hacihasanoglu4, Sevim Baykal Koca2, Zuhal Gucin5.   

Abstract

Primary breast carcinoma with neuroendocrine features (NEBC) is an uncommon tumor. In the classification of WHO 2012, these tumors were categorized as: 1- neuroendocrine tumor, well-differentiated; 2- neuroendocrine carcinoma, poorly differentiated/small cell carcinoma; and 3- invasive breast carcinoma with neuroendocrine differentiation. In this study, we reviewed NEBC except poorly differentiated/small cell carcinoma variant in order to define the morphological growth patterns and cytonuclear details of these tumors. All breast surgical excision materials between 2007 and 2016 were re-evaluated in terms of neuroendocrine differentiation. Thirty-six cases showing positive staining for synaptophysin and/or chromogranin A in ≥50% of tumor cells were included in the study. All cases were female with a mean age of 67.4. Mean tumor diameter was 26 mm. Multifocality was noted in 5 cases. Grossly, they were mostly infiltrative mass lesions. T stages, identified in 34 cases, were as follows: 13 cases with pT1; 19 pT2 and 2 pT3. We described schematically 4 types of patterns depending on predominant growth pattern, except one case: 1) Large-sized solid cohesive groups (6 cases), 2) Small- to medium-sized solid cohesive groups with trabeculae/ribbons and glandular structures (6 cases), 3) Mixed growth patterns (20 cases), 4) Invasive tumor with prominent extracellular and/or intracellular mucin (3 cases). The tumor cells were mostly polygonal-oval with eosinophilic/eosinophilic-granular cytoplasm. The nuclei of tumor cells were mostly round to oval with evenly distributed chromatin. Only 5 cases showed high grade nuclear and histological features. Molecular subtypes of the cases were as follows: 33 luminal A, 2 luminal B, and 1 triple negative. NEBC should come to mind when a tumor display one of the morphological patterns described above, composed of monotonous cells with mild to moderate nuclear pleomorphism and abundant eosinophilic/eosinophilic granular or clear cytoplasm, especially in elderly patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast; Neuroendocrine carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29661717     DOI: 10.1016/j.anndiagpath.2018.03.010

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  6 in total

1.  A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysis.

Authors:  Yu-Qiu Chen; Xiao-Fan Xu; Jia-Wei Xu; Tian-Yu Di; Xu-Lin Wang; Li-Qun Huo; Lu Wang; Jun Gu; Guo-Hua Zhou
Journal:  Transl Oncol       Date:  2022-06-11       Impact factor: 4.803

2.  Neuroendocrine Tumors of the Breast: Single-Center Experience.

Authors:  Bermal Hasbay; Hüseyin Özgür Aytaç; Filiz Aka Bolat
Journal:  Eur J Breast Health       Date:  2021-12-30

Review 3.  Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues.

Authors:  Marco Gallo; Severo Campione; Valentina Di Vito; Nicoletta Fortunati; Fabio Lo Calzo; Erika Messina; Rosaria Maddalena Ruggeri; Antongiulio Faggiano; Annamaria Anita Livia Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-26       Impact factor: 5.555

Review 4.  Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the Literature.

Authors:  Yukinori Ozaki; Sakiko Miura; Ryosuke Oki; Teppei Morikawa; Keita Uchino
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 5.  Neuroendocrine Cancer of the Breast: A Rare Entity.

Authors:  Azzurra Irelli; Maria Maddalena Sirufo; Luca Morelli; Carlo D'Ugo; Lia Ginaldi; Massimo De Martinis
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

6.  Primary neuroendocrine carcinoma of the breast with markedly elevated alpha-fetoprotein: a case report.

Authors:  Jia Wang; Xichen Wang; Wenlong Du; Yuanxian Guo; Xiaoping Yang; Jiebin Pan; Lanning Yin
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.